31
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The Absence of CD44 Ameliorates Faslpr/lpr Disease

Pages 1-8 | Received 12 Jun 2003, Accepted 23 Sep 2003, Published online: 07 Jul 2009
 

Abstract

The lpr mutation in the Fas gene leads to symptoms of autoimmune disease, including polyclonal B-lymphocyte activation and lymphoproliferation. The expanding T-lymphocyte populations in the disease are characterized by high expression levels of the memory marker CD44. It has not been known whether CD44 expression contributes to the pathophysiology of the condition or merely reflects a consequence of excessive lymphocyte activation. We therefore tested the role of CD44 gene products in Faslpr/lpr disease in gene targeted mice. We bred CD44 knockout mice and C57Bl/6-lpr mice to generate the Faslpr/lpr CD44+/+, and Faslpr/lpr CD44−/− genotypes and analyzed the disease manifestations around 215 days of age. The absence of CD44 substantially reduced the immunoglobulin secretion and lymphocyte expansion that are characteristic of the Faslpr/lpr syndrome. Surprisingly, the percentage of CD3+CD4CD8 (double negative) cells in peripheral lymphoid organs increased in Faslpr/lpr CD44−/− mice almost to the same extent as in Faslpr/lpr CD44+/+ mice. These results indicate that the expansion of the fraction of double negative cells in spleens and lymph nodes, believed to be generated by down-regulation of CD8, does not depend on increased lymphocyte numbers. Furthermore, they corroborate an essential role for CD44 gene products in the T-cell expansion and polyclonal B-cell activation that constitute the Faslpr/lpr syndrome. The CD44 receptor may be a suitable therapeutic target for inhibition of lymphoproliferation in autoimmune diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.